Search Results - "El Dershaby, Yasser"

Review of biologics, biosimilars, and intended copies in rheumatology, and current practice in Iraq by Al Ani, Nizar Abdulateef, Gorial, Faiq I, Al-Sulaitti, Saad, Humadi, Jasmine Abbas, Awadh, Nabaa Ihsan, Mounir, Mohamed, Dershaby, Yasser El, Jones, Heather, Sunna, Nancy

“…Biologic therapies are an important option in the treatment of patients with rheumatic disease. As the development of potential biosimilars increases, many…”
Get full text

Nurse-led care for the management of rheumatoid arthritis: a review of the global literature and proposed strategies for implementation in Africa and the Middle East by Uthman, Imad, Almoallim, Hani, Buckley, Christopher D., Masri, Basel, Dahou-Makhloufi, Chafia, El Dershaby, Yasser, Sunna, Nancy, Raza, Karim, Kumar, Kanta, Abu-Saad Huijer, Huda, Tashkandi, Nabeeha, Louw, Ingrid, Adelowo, Olufemi

“…Globally, increasing demand for rheumatology services has led to a greater reliance on non-physician healthcare professionals (HCPs), such as rheumatology…”
Get full text

Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries by El Zorkany, Bassel, Al Ani, Nizar, Al Emadi, Samar, Al Saleh, Jamal, Uthman, Imad, El Dershaby, Yasser, Mounir, Mohamed, Al Moallim, Hani

“…The increasing availability of biosimilar medicines in Middle Eastern regions may provide an opportunity to increase the number of rheumatology patients who…”
Get full text

Biosimilars in Rheumatic Diseases: Regulatory Guidelines, Efficacy and Safety Implications in Saudi Arabia by Halabi, Hussein, Al Zahrani, Zeyad, Al Swailem, Ramiz, Husain, Waleed, Al Rayes, Hanan, Al Osaimi, Hanan, El Dershaby, Yasser, Ahmed, Haytham Mohamed, Mounir, Mohamed, Omair, Mohammed A.

“…Background: Treatment with biologic drugs has enabled many patients with inflammatory rheumatic disease to achieve disease control. In some areas of the world,…”
Get full text

Regulatory Perspectives on Biopharmaceuticals for Chronic Inflammatory Diseases in North Africa: A Narrative Review by Mkinsi, Ouafa, Lefkir-Tafiani, Salima, Srairi, Héla S, Kochbati, Samir, El Dershaby, Yasser M., El Azhari, Mohamed M., Midjek, Sabrina A-I., Ladjouze-Rezig, Aicha

“…Introduction of innovative biopharmaceuticals has dramatically changed the treatment of chronic inflammatory diseases, but access to these very effective…”
Get full text